When it comes to the diabetes space, Dexcom is one of the heavy hitters. Its work in the continuous glucose monitoring space has put it on the map. In 2018, its Dexcom G6, an integrated continuous ...

Shares of DexCom (DXCM) declined 10% on Friday after investment firm Hunterbrook Capital disclosed a short position in the ...

The company is presenting several abstracts during the five-day conference showcasing clinical and real-world evidence that ...

Researchers who use Fitabase to capture data from Fitbit and Garmin devices will soon be able to capture a new kind of data: continuous glucose monitoring data from Dexcom products. The ability to ...

Shares of DexCom (NASDAQ: DXCM), a diabetes company focused on continuous glucose monitoring, fell as much as 10% in afternoon trading on Friday. The stock was down about 8% as of 3:14 p.m. EDT. The ...

Dexcom posted FY19 sales expectations on Monday and they are even better than the company forecast in Q3 at $1.47bn - a 42% year-on-year increase. Company drove revenues by 49% year-on-year in Q3 to ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), and Verily, an Alphabet company, announced an amendment to the Collaboration and License ...

DexCom Q4 revenue beat at $1.114B, up 8% Y/Y, but EPS missed at $0.45 vs. $0.50 consensus. FY25 guidance reaffirmed with $4.6B revenue target and 21% operating margin. Get stock picks, daily rankings, ...

Shares of DexCom recently soared after the company reported better-than-expected third-quarter results. DexCom markets constant blood-glucose monitors for diabetic patients, and its next-generation ...

In its most recent round of layoffs, Dexcom cuts 3% of its global workforce, targeting mostly San Diego-based employees.